Susana Perez-Gutthann, MD, PhD
Vice President, Global Head of Epidemiology
RTI Health Solutions
In November 2020, the European Network of Centers for Pharmacoepidemiology & Pharmacovigilance (ENCePP) announced its 2021–2023 steering group roster. Susana Perez-Gutthann, MD, PhD, Vice President, Global Head of Epidemiology at RTI Health Solutions (RTI-HS), is among those serving as part of this term's incoming ENCePP steering group. On January 18, Dr. Perez-Gutthann was elected as co-chair of the committee as well.
She shares, "I am honored to serve on the ENCePP Steering Committee on behalf of research centers in Europe. The role of ENCePP in assuring the validity of pharmacoepidemiological research is vital. As we move forward, we will continue our work to ensure that best practices and best methods will guide post-authorization safety studies for medical products in the EU. I look forward to collaborating with my fellow members of the steering group and the working groups that make all the activities of the network happen."
ENCePP operates under the European Medicines Agency's auspices and works to advance independent and transparent post-authorization monitoring of medical products in Europe. Its steering group includes a wide diversity of stakeholders that include members of EMA and other agencies, researchers, patients, and professional societies.
The ENCePP steering group defines and safeguards the group's objectives, principles, and operational tasks. Visit RTI-HS's profile on the ENCePP website. RTI Health Solutions is proud to have been a member of ENCePP since its inception in 2007.